Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA01050351 12,13 diHOME cPLA2i 1.0 BCD110605C28 0.036 pmol/ml medium
LMFA01050351 12,13 diHOME cPLA2i 1.0 BCD110605C30 0.035 pmol/ml medium
LMFA01050351 12,13 diHOME cPLA2i 1.0 BCD110605C29 0.03 pmol/ml medium
LMFA01050351 12,13 diHOME cPLA2i 20.0 BCD110605C64 0.044 pmol/ml medium
LMFA01050351 12,13 diHOME cPLA2i 20.0 BCD110605C66 0.032 pmol/ml medium
LMFA01050351 12,13 diHOME cPLA2i 20.0 BCD110605C65 0.029 pmol/ml medium
LMFA01050351 12,13 diHOME PLDi 1.0 BCD110605C16 0.043 pmol/ml medium
LMFA01050351 12,13 diHOME PLDi 1.0 BCD110605C17 0.04 pmol/ml medium
LMFA01050351 12,13 diHOME PLDi 1.0 BCD110605C18 0.042 pmol/ml medium
LMFA01050351 12,13 diHOME PLDi 20.0 BCD110605C54 0.041 pmol/ml medium
LMFA01050351 12,13 diHOME PLDi 20.0 BCD110605C52 0.043 pmol/ml medium
LMFA01050351 12,13 diHOME PLDi 20.0 BCD110605C53 0.043 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+cPLA2i 1.0 BCD110605C32 0.035 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+cPLA2i 1.0 BCD110605C31 0.029 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+cPLA2i 1.0 BCD110605C33 0.035 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+cPLA2i 20.0 BCD110605C68 0.033 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+cPLA2i 20.0 BCD110605C69 0.033 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+cPLA2i 20.0 BCD110605C67 0.028 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+PLDi 1.0 BCD110605C19 0.033 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+PLDi 1.0 BCD110605C20 0.036 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+PLDi 1.0 BCD110605C21 0.042 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+PLDi 20.0 BCD110605C56 0.04 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+PLDi 20.0 BCD110605C57 0.04 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+PLDi 20.0 BCD110605C55 0.035 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+cPLA2i 1.0 BCD110605C37 0.031 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+cPLA2i 1.0 BCD110605C38 0.048 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+cPLA2i 1.0 BCD110605C39 0.028 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+cPLA2i 20.0 BCD110605C74 0.035 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+cPLA2i 20.0 BCD110605C75 0.03 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+cPLA2i 20.0 BCD110605C73 0.028 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+PLDi 1.0 BCD110605C25 0.027 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+PLDi 1.0 BCD110605C27 0.036 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+PLDi 1.0 BCD110605C26 0.04 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+PLDi 20.0 BCD110605C61 0.031 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+PLDi 20.0 BCD110605C62 0.036 pmol/ml medium
LMFA01050351 12,13 diHOME KDO+ATP+PLDi 20.0 BCD110605C63 0.042 pmol/ml medium
LMFA01050351 12,13 diHOME KDO + ATP 1.0 BCD110605C15 0.038 pmol/ml medium
LMFA01050351 12,13 diHOME KDO + ATP 1.0 BCD110605C14 0.033 pmol/ml medium
LMFA01050351 12,13 diHOME KDO + ATP 1.0 BCD110605C13 0.041 pmol/ml medium
LMFA01050351 12,13 diHOME KDO + ATP 20.0 BCD110605C49 0.028 pmol/ml medium
LMFA01050351 12,13 diHOME KDO + ATP 20.0 BCD110605C50 0.04 pmol/ml medium
LMFA01050351 12,13 diHOME KDO + ATP 20.0 BCD110605C51 0.025 pmol/ml medium
LMFA01050351 12,13 diHOME KDO 1.0 BCD110605C08 0.058 pmol/ml medium
LMFA01050351 12,13 diHOME KDO 1.0 BCD110605C07 0.039 pmol/ml medium
LMFA01050351 12,13 diHOME KDO 1.0 BCD110605C09 0.042 pmol/ml medium
LMFA01050351 12,13 diHOME KDO 20.0 BCD110605C45 0.035 pmol/ml medium
LMFA01050351 12,13 diHOME KDO 20.0 BCD110605C44 0.033 pmol/ml medium
LMFA01050351 12,13 diHOME KDO 20.0 BCD110605C43 0.039 pmol/ml medium
LMFA01050351 12,13 diHOME C 0.0 BCD110605C03 0.048 pmol/ml medium
LMFA01050351 12,13 diHOME C 0.0 BCD110605C01 0.108 pmol/ml medium